Immunoassay For Detection Of Amniotic Fluid Protein(S).
NQM · Class I — Low Risk (general controls) · Clinical Chemistry · 21 CFR 862.1550
Classification
FDA Product Code
NQM
Device class
Class I — Low Risk (general controls)
Regulation
21 CFR 862.1550
Review panel
CH
Medical specialty
Clinical Chemistry
Submission type
4
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
The test is for use by health care professionals to aid in the detection of fetal membrane rupture in pregnant women, when they report signs, symptoms or complaints suggestive of such rupture.